OLFML2A

UniProt ID: A0A8C9H4D2
Organism: Piliocolobus tephrosceles
Review Status: COMPLETE
๐Ÿ“ Provide Detailed Feedback

Gene Description

OLFML2A (olfactomedin-like 2A, photomedin-1) is a member of the olfactomedin domain protein family (PANTHER PTHR23192, subfamily SF29). The full-length protein is a secreted glycoprotein. It has a signal peptide, two tandem N-terminal CXCXCX9C cysteine motifs, a coiled coil and a C-terminal olfactomedin domain. In mouse it is secreted as a disulfide-linked dimer and binds the sulfated glycosaminoglycans chondroitin sulfate E and heparin. This accession (439 aa) is the short isoform of the Ugandan red colobus gene, corresponding to human isoform 3, which is transcribed from an alternative first exon. It keeps the complete olfactomedin domain but lacks the signal peptide, both cysteine motifs and the coiled coil. Whether this short product is made, and where it is located or what it does, has not been tested. The full-length product of the same gene is A0A8C9H9A8.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005576 extracellular region
IEA
GO_REF:0000044
MARK AS OVER ANNOTATED
Summary: Electronic mapping of a UniProt "Secreted" subcellular location, which was assigned to this record by an ARBA rule. Secretion is established for full-length photomedin-1. This accession is the short isoform and has no signal peptide.
Reason: The full-length OLFML2A product (A0A8C9H9A8 in this species, Q68BL7-1 in human) is a secreted protein, and extracellular region is correct for the gene. A0A8C9H4D2 starts at an alternative first exon and lacks residues equivalent to human 1-222, so it has no signal peptide. It would not be expected to enter the classical secretory pathway, and there is no evidence that it is released by any other route. The ARBA-derived secretion annotation was applied to this record without considering that the signal peptide is missing. The term should be kept on the full-length product, not on this short isoform.
Supporting Evidence:
file:9PRIM/A0A8C9H4D2/A0A8C9H4D2-bioinformatics/RESULTS.md
It retains the complete C-terminal olfactomedin domain but lacks the signal peptide, both CXCXCX9C motifs and the coiled coil.
PMID:15836428
were secreted as disulphide-bonded dimers (photomedin-1) or oligomers/multimers (photomedin-2) with O-linked carbohydrate chains
GO:0007165 signal transduction
IEA
GO_REF:0000118
UNDECIDED
Summary: TreeGrafter transfer of the PAINT signal-transduction placement for the olfactomedin family. The donors behind that node are myocilin and other olfactomedins, not OLFML2A.
Reason: The PAINT IBD for GO:0007165 in PTHR23192 sits at PTN000573635 (Bilateria) and is seeded by MYOC (Q99972) and two mouse olfactomedins. This is a deliberate phylogenetic placement, and OLFML2A (SF29) falls within it. There is no OLFML2A-specific evidence that confirms or refutes inheritance of a signal-transduction role. The only experiments on OLFML2A show secretion, dimerization and glycosaminoglycan binding. The cancer cell-line studies show only correlation or perturbation effects on signaling. In addition, this short isoform lacks the signal peptide that an extracellular signaling role would require. I keep the same UNDECIDED judgment as the human OLFML2A IBA row rather than removing an inherited annotation without evidence against it.
Supporting Evidence:
file:9PRIM/A0A8C9H4D2/A0A8C9H4D2-bioinformatics/RESULTS.md
Whether this short transcript is translated, and where the product goes, has not been tested in any species
PMID:15836428
Among a panel of ECM components, including glycosaminoglycans, photomedins preferentially bound to chondroitin sulphate-E and heparin.

Core Functions

Retains the complete olfactomedin domain of photomedin-1. For the full-length secreted OLFML2A protein, the established activity is binding of sulfated extracellular glycosaminoglycans (chondroitin sulfate E, heparin). It is not known whether this short isoform, which lacks the signal peptide and the N-terminal dimerization-motif region, is made or has this activity.

Molecular Function:
extracellular matrix binding
Supporting Evidence:
  • PMID:15836428
    Among a panel of ECM components, including glycosaminoglycans, photomedins preferentially bound to chondroitin sulphate-E and heparin.
  • file:9PRIM/A0A8C9H4D2/A0A8C9H4D2-uniprot.txt
    PANTHER; PTHR23192:SF29; OLFACTOMEDIN-LIKE PROTEIN 2A; 1.
  • file:9PRIM/A0A8C9H4D2/A0A8C9H4D2-bioinformatics/RESULTS.md
    It retains the complete C-terminal olfactomedin domain but lacks the signal peptide, both CXCXCX9C motifs and the coiled coil.

References

Loading supporting contentโ€ฆ

Download this section (compressed HTML)

Suggested Questions for Experts

Q: Is the short alternative-first-exon OLFML2A transcript (human isoform 3, Piliocolobus XP_023072933.1) translated? If so, where does the signal-peptide-less product go, and does its olfactomedin domain alone bind chondroitin sulfate E or heparin?

Q: Should the ARBA "Secreted" rule exclude UniProt records that lack a predicted signal peptide, such as this N-terminally truncated isoform?

Suggested Experiments

Experiment: Express tagged full-length and short-isoform OLFML2A in HEK293 cells. Compare intracellular and conditioned-medium fractions under non-reducing and reducing SDS-PAGE, and test purified olfactomedin-domain protein for binding to chondroitin sulfate E and heparin by solid-phase assay.

Hypothesis: The olfactomedin domain alone, as encoded by the short isoform, is not secreted but keeps glycosaminoglycan-binding activity.

Type: biochemical localization and binding assay

External Prediction Reviews

These computational predictions are reviewed separately from the GOA annotation set used for this review. The assessments below are from this project and do not constitute official GO annotations or endorsement by GO/UniProt. They are not included in the existing annotation review above.

ProtNLM2 External predictions

View prediction review YAML ยท A0A8C9H4D2-protnlm-predictions-review.yaml ยท Review status: COMPLETE

A0A8C9H4D2 is the 439-residue short alternative-first-exon isoform of Ugandan red colobus OLFML2A (counterpart of human isoform 3). It keeps the olfactomedin domain but lacks the signal peptide, both CXCXCX9C motifs and the coiled coil of full-length photomedin-1; the full-length product of the same gene is A0A8C9H9A8. Mouse photomedin-1 experiments establish secretion, matrix association and glycosaminoglycan binding for the full-length protein. Extracellular matrix localization is rejected for this signal-peptide-less product, consistent with the gene review's judgment that extracellular region is over-annotated here. Extracellular matrix organization is unresolved: the only experimental support is an acts_upstream_of_or_within mouse annotation from an ECM screen that the mouse review leaves UNDECIDED, and no PubMed record reports a matrix-assembly result for any OLFML2A ortholog.

Source documents: genes/9PRIM/A0A8C9H4D2/A0A8C9H4D2-uniprot.txt ยท genes/9PRIM/A0A8C9H4D2/A0A8C9H4D2-goa.tsv ยท genes/9PRIM/A0A8C9H4D2/A0A8C9H4D2-ai-review.yaml ยท genes/9PRIM/OLFML2A__A0A8C9H9A8/OLFML2A__A0A8C9H9A8-ai-review.yaml ยท genes/mouse/Olfml2a/Olfml2a-ai-review.yaml ยท interpro/panther/PTHR23192/PTHR23192-review.yaml ยท publications/PMID_15836428.md ยท genes/9PRIM/A0A8C9H4D2/A0A8C9H4D2-prediction-evidence/Q8BHP7-uniprot.txt ยท genes/9PRIM/A0A8C9H4D2/A0A8C9H4D2-prediction-evidence/Q8BHP7-matrix-organization-quickgo.json ยท publications/PMID_18757743.md

Review score: 2 = concordant with evidence; 1 = uncertain; 0 = discordant with evidence. This is an assessment score, not a model probability.

GO:0031012 extracellular matrix GO_CC
NPI โ€” Nonparalog incorrect Review score: 0/2
Prediction method: ProtNLM2 ยท Version: UniProt 2024_06 pilot
DOMAIN ARCHITECTURE MISMATCH
Review rationale: Extracellular matrix is correct for full-length OLFML2A: mouse photomedin-1 (Q8BHP7, same PANTHER subfamily PTHR23192:SF29) is experimentally secreted and binds chondroitin sulphate-E and heparin (PMID:15836428), and the review of the full-length red colobus product A0A8C9H9A8 proposes this location. This accession, however, is the short isoform that starts at an alternative first exon and lacks the region carrying the signal peptide, both CXCXCX9C motifs and the coiled coil. Without a signal peptide it is not expected to enter the classical secretory pathway, and there is no evidence of release by another route. The gene review marks the parent location, extracellular region (GO:0005576, an ancestor of GO:0031012 by OLS4), as over-annotated on this product for that reason, which equally refutes the more specific matrix location. The prediction transfers a full-length-protein property to a product lacking the required targeting segment. The term is absent from GOA for both products of the gene, so it would have been novel.
Supporting Evidence:
GO:0030198 extracellular matrix organization GO_BP
UNC โ€” Uncertain Review score: 1/2
Prediction method: ProtNLM2 ยท Version: UniProt 2024_06 pilot
Review rationale: This accession is the 439-residue short isoform that starts at an alternative first exon (counterpart of human isoform 3). Its residues 9-439 align to residues 225-655 of the full-length product of the same gene, A0A8C9H9A8, which carries a SignalP signal peptide at 1-27; A0A8C9H4D2 has no counterpart of that region and so lacks the signal peptide, both CXCXCX9C motifs and the coiled coil, and is not expected to enter the classical secretory pathway. That absence does not settle the process term, because no mechanism of OLFML2A participation in extracellular matrix organization has been demonstrated, so it cannot be shown that the missing segment accounts for that participation, and no experiment refutes a contribution by this product. The only experimental basis is an MGI IDA annotation of mouse Olfml2a (Q8BHP7, PTHR23192:SF29) with the acts_upstream_of_or_within qualifier, from a systematic screen of candidate secreted proteins for matrix-assembling activities (PMID:18757743), which the mouse review leaves UNDECIDED because the Olfml2a-specific result is not visible. Secretion and glycosaminoglycan binding of full-length photomedin-1 (PMID:15836428) make a matrix role plausible for the full-length product, but no assembly result exists for any ortholog. Whether this short product is translated or released has not been tested. The prediction can be neither validated nor refuted. Neither product of the gene carries the term in GOA.
Supporting Evidence:

Deep Research

Falcon

(A0A8C9H4D2-deep-research-falcon.md)

Loading supporting contentโ€ฆ

Download this section (compressed HTML)

๐Ÿ“š Additional Documentation

Notes

(A0A8C9H4D2-notes.md)

Loading supporting contentโ€ฆ

Download this section (compressed HTML)

Bioinformatics Results

(RESULTS.md)

Loading supporting contentโ€ฆ

Download this section (compressed HTML)

๐Ÿ“„ View Raw YAML

Loading supporting contentโ€ฆ

Download this section (compressed HTML)